Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders
Introduction: Long-acting injectable buprenorphine (LAIB) is a relatively novel pharmacological treatment for people with opioid dependence. Despite growing qualitative evidence, there is limited research on practitioner insights, and effectiveness of LAIB in a community setting. Methods: Thirteen s...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Drug and Alcohol Dependence Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772724625000113 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849734156176588800 |
|---|---|
| author | Rebecca Fish Céu Mateus Hannah Maiden Euan Lawson Mark Limmer |
| author_facet | Rebecca Fish Céu Mateus Hannah Maiden Euan Lawson Mark Limmer |
| author_sort | Rebecca Fish |
| collection | DOAJ |
| description | Introduction: Long-acting injectable buprenorphine (LAIB) is a relatively novel pharmacological treatment for people with opioid dependence. Despite growing qualitative evidence, there is limited research on practitioner insights, and effectiveness of LAIB in a community setting. Methods: Thirteen service-users (11 currently prescribed LAIB), 6 practitioners, and 4 stakeholders (public health workers) took part in semi-structured interviews (n = 23) to glean their perspectives on LAIB. They were recruited through a community drug treatment service in the NW of England. The interview schedule was informed by previous literature and co-produced with a peer worker with lived experience of drug recovery treatment. Transcripts were analysed thematically by the research team. Results: Four major themes were identified from the interviews: A change of focus; challenges; wrap-around support; and target groups. Discussion: Our findings support existing evidence around the individual benefits to service-users such as changes to lifestyle and reduction of stigma, as well as challenges such as the need for wrap-around support and accessible information. We found that commissioning considerations such as geographical inequalities and the need for multi-service collaboration are important in this setting. Conclusions: LAIB treatment works well for many people in a community context that offers significant wrap-around support to service-users. The novelty of this research lies in bringing together the views of practitioners and stakeholders as well as treatment/service beneficiaries in evaluating the introduction of LAIB in a community service. |
| format | Article |
| id | doaj-art-c270a34a7cc54ea1b6c03e7d96619d95 |
| institution | DOAJ |
| issn | 2772-7246 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Drug and Alcohol Dependence Reports |
| spelling | doaj-art-c270a34a7cc54ea1b6c03e7d96619d952025-08-20T03:07:51ZengElsevierDrug and Alcohol Dependence Reports2772-72462025-06-011510032810.1016/j.dadr.2025.100328Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholdersRebecca Fish0Céu Mateus1Hannah Maiden2Euan Lawson3Mark Limmer4Division of Health Research, Lancaster University, UK; Corresponding author.Division of Health Research, Lancaster University, UKDivision of Health Research, Lancaster University, UKLancaster Medical School, Lancaster University, UKDivision of Health Research, Lancaster University, UKIntroduction: Long-acting injectable buprenorphine (LAIB) is a relatively novel pharmacological treatment for people with opioid dependence. Despite growing qualitative evidence, there is limited research on practitioner insights, and effectiveness of LAIB in a community setting. Methods: Thirteen service-users (11 currently prescribed LAIB), 6 practitioners, and 4 stakeholders (public health workers) took part in semi-structured interviews (n = 23) to glean their perspectives on LAIB. They were recruited through a community drug treatment service in the NW of England. The interview schedule was informed by previous literature and co-produced with a peer worker with lived experience of drug recovery treatment. Transcripts were analysed thematically by the research team. Results: Four major themes were identified from the interviews: A change of focus; challenges; wrap-around support; and target groups. Discussion: Our findings support existing evidence around the individual benefits to service-users such as changes to lifestyle and reduction of stigma, as well as challenges such as the need for wrap-around support and accessible information. We found that commissioning considerations such as geographical inequalities and the need for multi-service collaboration are important in this setting. Conclusions: LAIB treatment works well for many people in a community context that offers significant wrap-around support to service-users. The novelty of this research lies in bringing together the views of practitioners and stakeholders as well as treatment/service beneficiaries in evaluating the introduction of LAIB in a community service.http://www.sciencedirect.com/science/article/pii/S2772724625000113Opioid agonist therapyLong acting injectable buprenorphineRecoveryHarm reductionQualitative |
| spellingShingle | Rebecca Fish Céu Mateus Hannah Maiden Euan Lawson Mark Limmer Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders Drug and Alcohol Dependence Reports Opioid agonist therapy Long acting injectable buprenorphine Recovery Harm reduction Qualitative |
| title | Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders |
| title_full | Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders |
| title_fullStr | Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders |
| title_full_unstemmed | Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders |
| title_short | Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders |
| title_sort | long acting injectable buprenorphine perspectives from service users staff and stakeholders |
| topic | Opioid agonist therapy Long acting injectable buprenorphine Recovery Harm reduction Qualitative |
| url | http://www.sciencedirect.com/science/article/pii/S2772724625000113 |
| work_keys_str_mv | AT rebeccafish longactinginjectablebuprenorphineperspectivesfromserviceusersstaffandstakeholders AT ceumateus longactinginjectablebuprenorphineperspectivesfromserviceusersstaffandstakeholders AT hannahmaiden longactinginjectablebuprenorphineperspectivesfromserviceusersstaffandstakeholders AT euanlawson longactinginjectablebuprenorphineperspectivesfromserviceusersstaffandstakeholders AT marklimmer longactinginjectablebuprenorphineperspectivesfromserviceusersstaffandstakeholders |